Medicare Enrolled

Dr. Thomas Swain, MD

Cardiovascular Disease · Melbourne, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1223 GATEWAY DR, Melbourne, FL 32901
3217254500
In practice since 2005 (20 years)
NPI: 1881670479 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Swain from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Swain? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Swain

Dr. Thomas Swain is a cardiovascular disease in Melbourne, FL, with 20 years in practice. Based on federal Medicare data, Dr. Swain performed 12,881 Medicare services across 3,802 unique beneficiaries.

Between the years covered by Open Payments, Dr. Swain received a total of $8,413 from 28 pharmaceutical and/or device companies across 215 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Swain is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 5% volume in FL$ $8,413 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,881
Medicare services
Top 5% in FL for cardiovascular disease
3,802
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~644 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)7,742$0$2
Office visit, established patient (30-39 min)991$92$255
Electrocardiogram (EKG), 12-lead748$10$33
Echocardiogram, transthoracic497$133$385
Technetium tc-99m sestamibi, diagnostic, per study dose392$87$228
Remote pacemaker/defibrillator monitoring, 90 days316$15$46
Remote pacemaker monitoring, 90 days213$21$60
Nuclear medicine studies of heart muscle at rest and with stress and spect192$323$853
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician175$47$139
New patient office visit (45-59 min)172$116$335
Electrocardiogram (ecg) 2-day continuous with review by health care professional169$13$54
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec155$25$87
Evaluation of cardiac rhythm monitor system, remote up to 30 days153$18$53
Programming of dual lead pacemaker system122$52$158
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days120$18$52
EKG interpretation and report103$6$18
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days103$25$116
Evaluation of implantable heart and blood vessel monitoring system77$33$107
Programming of multiple lead implantable defibrillator system70$77$210
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician68$11$28
Office visit, established patient, complex (40-54 min)56$132$359
Ultrasound of both sides of head and neck blood flow47$135$375
Ultrasound of heart, follow-up31$19$50
Programming of single lead pacemaker system30$50$134
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician24$16$43
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes21$10$26
Evaluation of single, dual, or multiple lead implantable defibrillator system19$51$144
Programming of dual lead implantable defibrillator system18$66$192
Hospital follow-up visit, moderate complexity17$63$160
Evaluation of single, dual, multiple lead or leadless pacemaker system15$43$111
Office visit, established patient (20-29 min)14$63$181
Initial hospital admission, moderate complexity11$103$264
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.9% high complexity
64.3% medium
24.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,413
Total received (2018-2024)
Avg $1,202/year across 7 years
Top 28% in FL for cardiovascular disease
28
Companies
215
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,413 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$293
2023
$589
2022
$748
2021
$1,213
2020
$444
2019
$673
2018
$4,452

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
BIOTRONIK INC.
$4,999
Janssen Pharmaceuticals, Inc
$663
Novartis Pharmaceuticals Corporation
$386
PFIZER INC.
$287
Novo Nordisk Inc
$281
Amarin Pharma Inc.
$252
SANOFI-AVENTIS U.S. LLC
$212
E.R. Squibb & Sons, L.L.C.
$185
Amgen Inc.
$166
Abbott Laboratories
$131
Boehringer Ingelheim Pharmaceuticals, Inc.
$123
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$96
Boston Scientific Corporation
$93
CVRx, Inc.
$88
Gilead Sciences, Inc.
$85
Medtronic, Inc.
$64
Impulse Dynamics (USA) Inc.
$57
Braemar Manufacturing, LLC
$47
Esperion Therapeutics, Inc.
$35
Lundbeck LLC
$33
iRhythm Technologies, Inc.
$31
AstraZeneca Pharmaceuticals LP
$24
Lilly USA, LLC
$15
ABIOMED
$14
Bayer HealthCare Pharmaceuticals Inc.
$13
Aziyo Biologics, Inc.
$11
GENZYME CORPORATION
$11
Kowa Pharmaceuticals America, Inc.
$10
Top 3 companies account for 71.9% of total payments
Associated products mentioned in payments ›
AMVIA EDGE · ANDEXXA · Acticor · Acticor 7 VR-T DX · BIOMONITOR · Barostim Neo System · BioMonitor · BioMonitor 2 · CAMZYOS · CHANTIX · Cardiac Monitoring Suite · Corlanor · ECM Patch · ELIQUIS · ENTRESTO · Edora · FABRY-DISEASE · FARXIGA · HAWKONE · Impella · JARDIANCE · Kerendia · LifeVest · Livalo · MICRA · MOUNJARO · MULTAQ · MitraClip System · NEXLETOL · NORTHERA · OPTIMIZER · Optimizer Smart System · Ozempic · PRADAXA · PRALUENT · Pouch · Repatha · Reveal LINQ · Rivacor 7 DR-T · Selectra · Solia · VYNDAQEL · Vascepa · WATCHMAN · Wegovy · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $65 per 100 Medicare services performed
Looking for a cardiovascular disease in Melbourne?
Compare cardiovascular diseases in the Melbourne area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
37
Per 100K population
6.0
County median income
$75,817
Nearest hospital
HOLMES REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Swain is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Swain experienced with injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)?
Based on Medicare claims data, Dr. Swain performed 7,742 injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Swain receive payments from pharmaceutical companies?
Yes. Dr. Swain received a total of $8,413 from 28 companies across 215 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Swain's costs compare to other cardiovascular diseases in Melbourne?
Dr. Swain's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Swain) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →